OPTIMIZATION OF HIGH DOSE-RATE CERVIX BRACHYTHERAPY .1. DOSE DISTRIBUTION

被引:14
作者
HOUDEK, PV [1 ]
SCHWADE, JG [1 ]
ABITBOL, AA [1 ]
PISCIOTTA, V [1 ]
WU, XD [1 ]
SERAGO, CF [1 ]
MARKOE, AM [1 ]
LEWIN, AA [1 ]
AVERETTE, HE [1 ]
SEVIN, BU [1 ]
BRANDON, AH [1 ]
FIEDLER, JA [1 ]
COHEN, AM [1 ]
FAYAD, F [1 ]
机构
[1] UNIV MIAMI,SCH MED,DEPT OBSTET GYNECOL,MIAMI,FL 33101
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 21卷 / 06期
关键词
BRACHYTHERAPY; OPTIMIZATION; HIGH DOSE-RATE; RING APPLICATOR;
D O I
10.1016/0360-3016(91)90341-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Computer controlled high dose-rate (HDR) brachytherapy afterloading machines are equipped with a single, miniaturized, high activity Ir-192 source that can be rapidly moved in fine increments among several channels. Consequently, by appropriate programming of source dwell positions and times, the dose distribution can be optimized as desired. We have explored the optimization potential of this new technology for two applications: (a) cervix brachytherapy, and (b) transvaginal irradiation. Cervix brachytherapy with a gynecologic ring applicator was simulated by 48 sources of relative activities ranging from 0.17 to 1.00 that were equally distributed between the tandem and the ring. The results confirmed that the optimized distribution of physical doses are superior to those achievable with standard brachytherapy sources and applicators. For example, with five-point optimization, the relative dose-rate in the rectum was only 47% of that in point A; for standard application the dose rate was 47% higher. For transvaginal application 27 sources of relative activities between 0.07-0.79 were placed in the ring and a single source of unit strength in the tandem. Using dose distribution homogeneity as an optimization criterion, the results (+/- 2.5%) were again superior to those obtained for commonly used double ovoid (+/- 15%), linear cylinder (+/- 27%), or a "T" source (31%).
引用
收藏
页码:1621 / 1625
页数:5
相关论文
共 9 条
[1]  
ABITBOL A, 1990, ACTIVITY, V4, P68
[2]  
Hetzel H, 1989, BRACHYTHERAPY, V2, P136
[3]   TREATMENT OF CERVIX CANCER USING HIGH ACTIVITY CO-60 SOURCES [J].
JOSLIN, CAF ;
SMITH, CW ;
MALLIK, A .
BRITISH JOURNAL OF RADIOLOGY, 1972, 45 (532) :257-&
[4]   RADIATION ALONE IN THE TREATMENT OF CANCER OF THE UTERINE CERVIX - ANALYSIS OF PELVIC FAILURE AND DOSE-RESPONSE RELATIONSHIP [J].
KIM, RY ;
TROTTI, A ;
WU, CJ ;
SOONG, SJ ;
SALTER, MM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (05) :973-978
[5]   DOSE DEPENDENCE OF COMPLICATION RATES IN CERVIX CANCER RADIOTHERAPY [J].
ORTON, CG ;
WOLFROSENBLUM, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (01) :37-44
[6]   INTRACAVITARY APPLICATOR IN RELATION TO COMPLICATIONS OF PELVIC RADIATION - ERNST SYSTEM [J].
ROTMAN, M ;
JOHN, MJ ;
ROUSSIS, K ;
STONE, M ;
MOON, SH ;
CHOI, KN ;
CHAN, B ;
SALL, S ;
SYED, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (11-1) :951-956
[7]   AN ANALYSIS OF THE SEVERE COMPLICATIONS OF IRRADIATION OF CARCINOMA OF THE UTERINE CERVIX - TREATMENT WITH INTRACAVITARY RADIUM AND PARAMETRIAL IRRADIATION [J].
UNAL, A ;
HAMBERGER, AD ;
SESKI, JC ;
FLETCHER, GH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (08) :999-1004
[8]  
Van der Laarse R., 1989, ACTIVITY, V2, P14
[9]  
1985, ICRU38 REP